Prescription - Transparency and the Evolution of Compounding

Author(s):  Kupiec Thomas C

Issue:  May/Jun 2025 - Volume 29, Number 3
View All Articles in Issue

Abstract:  Ten years after the passage of Section 503B of the Drug Quality and Security Act, outsourcing facilities have become an embedded part of the compounding landscape. Pharmacies of all types 503A, 503B, hospital, investigational) are working not only to meet new standards but to define how those standards translate into consistent, high-quality care. From non-sterile and sterile formulations to microbial preservative and novel delivery systems, adaptation is no longer optional. It is a daily discipline.

Related Categories: BUSINESS, UNITED STATES PHARMACOPEIA CONVENTIONS

Purchase this article for download in electronic PDF format from IJPC at for $75 at:
https://ijpc.com/Abstracts/Abstract.cfm?ABS=5456

Search the entire IJPC archive by keyword, topic, or issue at:
https://ijpc.com/Products